Logo image of SABR

SABRE CORP (SABR) Stock Fundamental Analysis

NASDAQ:SABR - US78573M1045 - Common Stock

1.79 USD
0 (0%)
Last: 8/29/2025, 8:00:02 PM
1.79 USD
0 (0%)
After Hours: 8/29/2025, 8:00:02 PM
Fundamental Rating

3

Overall SABR gets a fundamental rating of 3 out of 10. We evaluated SABR against 134 industry peers in the Hotels, Restaurants & Leisure industry. Both the profitability and financial health of SABR have multiple concerns. SABR has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

SABR had negative earnings in the past year.
In the past year SABR has reported a negative cash flow from operations.
SABR had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: SABR reported negative operating cash flow in multiple years.
SABR Yearly Net Income VS EBIT VS OCF VS FCFSABR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B

1.2 Ratios

Looking at the Return On Assets, with a value of -8.11%, SABR is doing worse than 82.09% of the companies in the same industry.
SABR's Return On Invested Capital of 7.86% is fine compared to the rest of the industry. SABR outperforms 63.43% of its industry peers.
Industry RankSector Rank
ROA -8.11%
ROE N/A
ROIC 7.86%
ROA(3y)-8.94%
ROA(5y)-13.2%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SABR Yearly ROA, ROE, ROICSABR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400

1.3 Margins

SABR has a better Operating Margin (11.73%) than 63.43% of its industry peers.
SABR's Operating Margin has improved in the last couple of years.
The Gross Margin of SABR (57.79%) is better than 70.90% of its industry peers.
SABR's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 11.73%
PM (TTM) N/A
GM 57.79%
OM growth 3YN/A
OM growth 5Y1.94%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.27%
GM growth 5Y17.88%
SABR Yearly Profit, Operating, Gross MarginsSABR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so SABR is still creating some value.
Compared to 1 year ago, SABR has more shares outstanding
The number of shares outstanding for SABR has been increased compared to 5 years ago.
The debt/assets ratio for SABR is higher compared to a year ago.
SABR Yearly Shares OutstandingSABR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
SABR Yearly Total Debt VS Total AssetsSABR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

Based on the Altman-Z score of -0.45, we must say that SABR is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -0.45, SABR is not doing good in the industry: 87.31% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -0.45
ROIC/WACC1.07
WACC7.33%
SABR Yearly LT Debt VS Equity VS FCFSABR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B

2.3 Liquidity

A Current Ratio of 1.01 indicates that SABR should not have too much problems paying its short term obligations.
With a Current ratio value of 1.01, SABR perfoms like the industry average, outperforming 54.48% of the companies in the same industry.
SABR has a Quick Ratio of 1.01. This is a normal value and indicates that SABR is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.01, SABR perfoms like the industry average, outperforming 58.96% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.01
Quick Ratio 1.01
SABR Yearly Current Assets VS Current LiabilitesSABR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 44.00% over the past year.
The Revenue has decreased by -1.16% in the past year.
The Revenue has been decreasing by -5.29% on average over the past years.
EPS 1Y (TTM)44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60%
Revenue 1Y (TTM)-1.16%
Revenue growth 3Y21.5%
Revenue growth 5Y-5.29%
Sales Q2Q%-10.44%

3.2 Future

SABR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 30.59% yearly.
Based on estimates for the next years, SABR will show a small growth in Revenue. The Revenue will grow by 0.90% on average per year.
EPS Next Y112.08%
EPS Next 2Y82.02%
EPS Next 3Y51.1%
EPS Next 5Y30.59%
Revenue Next Year-6.8%
Revenue Next 2Y-1.47%
Revenue Next 3Y-0.36%
Revenue Next 5Y0.9%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SABR Yearly Revenue VS EstimatesSABR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1B 2B 3B 4B
SABR Yearly EPS VS EstimatesSABR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 1 -1 -2 -3

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

SABR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 7.17, which indicates a rather cheap valuation of SABR.
Based on the Price/Forward Earnings ratio, SABR is valued cheaply inside the industry as 95.52% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 22.76. SABR is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 7.17
SABR Price Earnings VS Forward Price EarningsSABR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SABR indicates a somewhat cheap valuation: SABR is cheaper than 60.45% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 11.56
SABR Per share dataSABR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 -10

4.3 Compensation for Growth

SABR's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as SABR's earnings are expected to grow with 51.10% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y82.02%
EPS Next 3Y51.1%

More info and screens

0

5. Dividend

5.1 Amount

SABR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SABRE CORP

NASDAQ:SABR (8/29/2025, 8:00:02 PM)

After market: 1.79 0 (0%)

1.79

0 (0%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)08-07 2025-08-07/bmo
Earnings (Next)10-29 2025-10-29/bmo
Inst Owners92.93%
Inst Owner Change2.85%
Ins Owners2.95%
Ins Owner Change18.11%
Market Cap706.17M
Analysts76.67
Price Target3.17 (77.09%)
Short Float %5.93%
Short Ratio2.83
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-294.41%
Min EPS beat(2)-488.82%
Max EPS beat(2)-100%
EPS beat(4)0
Avg EPS beat(4)-150.79%
Min EPS beat(4)-488.82%
Max EPS beat(4)-2.3%
EPS beat(8)3
Avg EPS beat(8)-58.96%
EPS beat(12)5
Avg EPS beat(12)-37.14%
EPS beat(16)8
Avg EPS beat(16)-25.12%
Revenue beat(2)0
Avg Revenue beat(2)-5.36%
Min Revenue beat(2)-6.19%
Max Revenue beat(2)-4.52%
Revenue beat(4)0
Avg Revenue beat(4)-4.06%
Min Revenue beat(4)-6.19%
Max Revenue beat(4)-2.22%
Revenue beat(8)1
Avg Revenue beat(8)-2.36%
Revenue beat(12)2
Avg Revenue beat(12)-2.74%
Revenue beat(16)3
Avg Revenue beat(16)-1.94%
PT rev (1m)-32.68%
PT rev (3m)-34.53%
EPS NQ rev (1m)-55.56%
EPS NQ rev (3m)-57.89%
EPS NY rev (1m)-82.14%
EPS NY rev (3m)-80.23%
Revenue NQ rev (1m)-4.16%
Revenue NQ rev (3m)-13.15%
Revenue NY rev (1m)-6.86%
Revenue NY rev (3m)-10.92%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 7.17
P/S 0.24
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 11.56
EPS(TTM)-0.14
EYN/A
EPS(NY)0.25
Fwd EY13.94%
FCF(TTM)-0.68
FCFYN/A
OCF(TTM)-0.49
OCFYN/A
SpS7.46
BVpS-4.61
TBVpS-11.42
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.11%
ROE N/A
ROCE 9.95%
ROIC 7.86%
ROICexc 8.96%
ROICexgc 75.68%
OM 11.73%
PM (TTM) N/A
GM 57.79%
FCFM N/A
ROA(3y)-8.94%
ROA(5y)-13.2%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5Y5.08%
OM growth 3YN/A
OM growth 5Y1.94%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.27%
GM growth 5Y17.88%
F-Score3
Asset Turnover0.67
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 10.86
Cap/Depr 65.67%
Cap/Sales 2.57%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.01
Quick Ratio 1.01
Altman-Z -0.45
F-Score3
WACC7.33%
ROIC/WACC1.07
Cap/Depr(3y)53.81%
Cap/Depr(5y)40.03%
Cap/Sales(3y)2.84%
Cap/Sales(5y)3.33%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60%
EPS Next Y112.08%
EPS Next 2Y82.02%
EPS Next 3Y51.1%
EPS Next 5Y30.59%
Revenue 1Y (TTM)-1.16%
Revenue growth 3Y21.5%
Revenue growth 5Y-5.29%
Sales Q2Q%-10.44%
Revenue Next Year-6.8%
Revenue Next 2Y-1.47%
Revenue Next 3Y-0.36%
Revenue Next 5Y0.9%
EBIT growth 1Y32%
EBIT growth 3YN/A
EBIT growth 5Y-3.45%
EBIT Next Year50.35%
EBIT Next 3Y19.29%
EBIT Next 5Y8.23%
FCF growth 1Y-8.59%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-18.38%
OCF growth 3YN/A
OCF growth 5Y-34.35%